Heron Therapeutics
HRTX
#7573
Rank
$0.26 B
Marketcap
$1.75
Share price
-1.13%
Change (1 day)
196.61%
Change (1 year)

P/S ratio for Heron Therapeutics (HRTX)

P/S ratio as of November 2024 (TTM): 1.95

According to Heron Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -7.00. At the end of 2024 the company had a P/S ratio of 3.87.

P/S ratio history for Heron Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.8792.56%
20232.01-27.25%
20222.76-74.39%
202110.8-50.56%
202021.849.97%
201914.5-44.46%
201826.2-30.68%
201737.8-90.59%
2016401
2015N/A
2014N/A
2013N/A
2012N/A-100%
201171.2411.52%
201013.9-65.11%
200939.913.61%
200835.134.06%
200726.2
20057.17-6.14%
20047.64-26.71%
200310.4181.79%
20023.70-71.51%
200113.0

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.10 59.39%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
1.15-40.76%๐Ÿ‡บ๐Ÿ‡ธ USA
2.77 42.13%๐Ÿ‡บ๐Ÿ‡ธ USA
16.6 752.60%๐Ÿ‡บ๐Ÿ‡ธ USA
4.54 133.32%๐Ÿ‡บ๐Ÿ‡ธ USA